Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, 1365C Clifton Road, Northeast 2nd Floor, Atlanta, GA 30322, USA.
Surg Clin North Am. 2011 Oct;91(5):1039-77. doi: 10.1016/j.suc.2011.06.009.
Gastric adenocarcinoma is one of the most common causes of death worldwide. Surgical resection remains the mainstay of therapy, offering the only chance for complete cure. Resection is based on the principles of obtaining adequate margins, with the extent of lymphadenectomy remaining controversial. Neoadjuvant and adjuvant therapies are used to reduce local recurrence and improve long-term survival. This article reviews the literature and provides a summary of surgical management options and neoadjuvant/adjuvant therapies for gastric adenocarcinoma.
胃腺癌是全球最常见的死亡原因之一。手术切除仍然是主要的治疗方法，是唯一能够完全治愈的机会。切除的基础是获得足够的切缘，淋巴结清扫的范围仍存在争议。新辅助和辅助治疗用于减少局部复发并提高长期生存率。本文回顾了文献，总结了胃腺癌的手术治疗选择和新辅助/辅助治疗。
